tiprankstipranks
Trending News
More News >
Tryptamine Therapeutics Limited (AU:ENP)
ASX:ENP
Australian Market

Tryptamine Therapeutics (ENP) Financial Statements

Compare
14 Followers

Tryptamine Therapeutics Financial Overview

Tryptamine Therapeutics's market cap is currently AU$51.65M. The company's EPS TTM is AU$; its P/E ratio is -7.27; Tryptamine Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueAU$ 0.00AU$ 0.00AU$ 618.57KAU$ 99.73KAU$ 0.00
Gross ProfitAU$ -54.34KAU$ -6.77KAU$ 618.57KAU$ 99.73KAU$ -1.01M
Operating IncomeAU$ -6.73MAU$ -4.97MAU$ -9.59MAU$ -14.11MAU$ -12.67M
EBITDAAU$ -5.27MAU$ -6.70MAU$ -5.10MAU$ -8.27MAU$ -11.66M
Net IncomeAU$ -5.33MAU$ -6.14MAU$ -7.13MAU$ -10.08MAU$ -8.47M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 3.03MAU$ 5.37MAU$ 1.64MAU$ 4.85MAU$ 12.72M
Total AssetsAU$ 6.66MAU$ 7.45MAU$ 5.88MAU$ 13.61MAU$ 21.46M
Total DebtAU$ 0.00AU$ 0.00AU$ 1.53MAU$ 3.74MAU$ 1.36M
Net DebtAU$ -3.03MAU$ -5.37MAU$ -109.30KAU$ -1.10MAU$ -11.37M
Total LiabilitiesAU$ 699.17KAU$ 1.83MAU$ 1.75MAU$ 4.81MAU$ 2.59M
Stockholders' EquityAU$ 5.96MAU$ 5.62MAU$ 4.13MAU$ 8.81MAU$ 18.87M
Cash Flow
Free Cash FlowAU$ -7.90MAU$ -6.00MAU$ -4.03MAU$ -9.72MAU$ -9.51M
Operating Cash FlowAU$ -7.77MAU$ -6.00MAU$ -4.03MAU$ -8.59MAU$ -7.89M
Investing Cash FlowAU$ -133.40KAU$ 1.68MAU$ -9.08KAU$ -1.24MAU$ -1.80M
Financing Cash FlowAU$ 5.60MAU$ 9.27MAU$ 2.39MAU$ 1.95MAU$ 20.61M
Currency in AUD

Tryptamine Therapeutics Earnings and Revenue History

Tryptamine Therapeutics Debt to Assets

Tryptamine Therapeutics Cash Flow

Tryptamine Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.